Biomarkers for Systemic Therapy in Metastatic Breast Cancer

Published: June 2022
  Looking for subscriptions?
  • Key Points
  • New Recommendations from 2022 Focused Guideline Update 
  • Recommendations Unchanged From 2015 Guideline 
  • At-A-Glance Guide to ASCO Biomarker Testing in Metastatic Breast Cancer Recommendations
  • For purchases under 100 in quantity, we suggest placing the order directly through the website.
  • We offer group/institutional licenses for multi-user accounts (discount amount varies depending on the number of users).
  • We are proud to offer special discounts to medical schools, training programs, students and more.
  • We offer bulk purchase discounts based on number of copies and number of titles.

Contact Us for more details

Founded in 1964, the American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer.

Description

This pocket guide is derived from recommendations in the American Society of Clinical Oncology Guideline. This resource is a practice tool based on ASCO® practice guidelines and is not intended to substitute for the independent professional judgment of the treating physician. Practice guidelines do not account for individual variation among patients. This pocket guide does not purport to suggest any particular course of medical treatment. Use of the practice guidelines and this resource are voluntary. The practice guidelines and additional information are available at www.asco.org/breast-cancer-guidelines. Copyright © 2022 by American Society of Clinical Oncology. All rights reserved.

Price:$9.95

Digital Download Information:
  • Supported on Apple and Android devices
  • Content is accessible offline
  • PDF Format
  • Download instantly from your account
Clear
Need help?